Title: P139 Fluticasone propionate and fluticasone/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma
Abstract: The present study evaluated fluticasone propionate (Fp), an inhaled corticosteroid (ICS), and Fp/salmeterol (FS), a combination ICS and long-acting beta2-agonist (LABA), delivered via a novel, inhalation-driven, multidose dry powder inhaler (MDPI) that does not require coordination of actuation with inhalation, in patients with persistent asthma.
Publication Year: 2016
Publication Date: 2016-11-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot